Artículos por temáticas

Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease

Suzuki K, Fujita H, Matsubara T, Haruyama Y, Kadowaki T, Funakoshi K, Watanabe Y, Hirata K.

Brain Behav. 2021 Mar;11(3):e02026. doi: 10.1002/brb3.2026. Epub 2021 Jan 5.

SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease

Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A.

Brain Sci. 2021 Jan 6;11(1):57. doi: 10.3390/brainsci11010057.

A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease

Lin CH, Chang CH, Tai CH, Cheng MF, Chen YC, Chao YT, Huang TL, Yen RF, Wu RM.

Mov Disord. 2021 May;36(5):1229-1237. doi: 10.1002/mds.28474. Epub 2021 Jan 15.

Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes

Harrison PJ, Colbourne L, Luciano S.

Br J Psychiatry. 2021 Jan 7:1-3. doi: 10.1192/bjp.2020.249. Online ahead of print.

Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease

Estevez-Fraga C, Scahill RI, Durr A, Leavitt BR, Roos RAC, Langbehn DR, Rees G, Gregory S, Tabrizi SJ.

Mov Disord. 2021 May;36(5):1259-1264. doi: 10.1002/mds.28489. Epub 2021 Jan 20.

Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease

Zarkali A, McColgan P, Leyland LA, Lees AJ, Weil RS.

Mov Disord. 2021 May;36(5):1191-1202. doi: 10.1002/mds.28477. Epub 2021 Jan 9.

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders

Constantinides VC, Majbour NK, Paraskevas GP, Abdi I, Safieh-Garabedian B, Stefanis L, El-Agnaf OM, Kapaki E.

Brain Sci. 2021 Jan 17;11(1):119. doi: 10.3390/brainsci11010119.

Brain MR patterns in inherited disorders of monoamine neurotransmitters: An analysis of 70 patients

Kuseyri Hübschmann O, Mohr A, Friedman J, Manti F, Horvath G, Cortès-Saladelafont E, Mercimek-Andrews S, Yildiz Y, Pons R, Kulhánek J, Oppebøen M, Koht JA, Podzamczer-Valls I, Domingo-Jimenez R, Ibáñe

J Inherit Metab Dis. 2021 Jul;44(4):1070-1082. doi: 10.1002/jimd.12360. Epub 2021 Jan 28.

Anesthetic Considerations for Functional Neurosurgery

Crawford L, Mueller D, Mathews L.

Anesthesiol Clin. 2021 Mar;39(1):227-243. doi: 10.1016/j.anclin.2020.11.013.

Allele-specific expression of Parkinson's disease susceptibility genes in human brain

Langmyhr M, Henriksen SP, Cappelletti C, van de Berg WDJ, Pihlstrøm L, Toft M.

Sci Rep. 2021 Jan 12;11(1):504. doi: 10.1038/s41598-020-79990-9.

A review of movement disorders in chemotherapy-induced neurotoxicity

Wang AB, Housley SN, Flores AM, Kircher SM, Perreault EJ, Cope TC.

J Neuroeng Rehabil. 2021 Jan 25;18(1):16. doi: 10.1186/s12984-021-00818-2.

Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease

Donahue EK, Murdos A, Jakowec MW, Sheikh-Bahaei N, Toga AW, Petzinger GM, Sepehrband F.

Mov Disord. 2021 May;36(5):1126-1136. doi: 10.1002/mds.28473. Epub 2021 Jan 20.

Epilepsy, status epilepticus, and hemiplegic migraine coexisting with a novel SLC4A4 mutation

Gil-Perotín S, Jaijo T, Verdú AG, Rubio P, Mazón M, Gasqué-Rubio R, Díaz S.

Neurol Sci. 2021 Jan 13. doi: 10.1007/s10072-020-04961-x. Online ahead of print.

Genotype-Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review

Lange LM, Junker J, Loens S, Baumann H, Olschewski L, Schaake S, Madoev H, Petkovic S, Kuhnke N, Kasten M, Westenberger A, Domingo A, Marras C, König IR, Camargos S, Ozelius LJ, Klein C, Lohmann K.

Mov Disord. 2021 May;36(5):1086-1103. doi: 10.1002/mds.28485. Epub 2021 Jan 27.

Objective detection of microtremors in netrin-G2 knockout mice

Ajima A, Yoshida T, Yaguchi K, Itohara S.

J Neurosci Methods. 2021 Mar 1;351:109074. doi: 10.1016/j.jneumeth.2021.109074. Epub 2021 Jan 13.